A-104 Examining Methods of Executive Ability from Trail Making Test Part B in Retired Football Players

2021 ◽  
Vol 36 (6) ◽  
pp. 1153-1153
Author(s):  
Daniel W Lopez-Hernandez ◽  
Bethany A Nordberg ◽  
Alexis Bueno ◽  
Pavel Y Litvin ◽  
Amy Bichlmeier ◽  
...  

Abstract Introduction Repeated sports-related concussions have been associated with cognitive deficits, similar to other forms of traumatic brain injury. We investigated three different measures of executive ability derived from the Trail Making Test part B (TMT-B) in healthy comparison (HC) adults and retired football players. Methods The sample consisted of 32 HC, 15 retired football speed players (FSP; e.g., quarterbacks), and 53 retired football non-speed players (FNP) participants. Participants were administered both TMT part A (TMT-A) and TMT-B, and total time for completion was recorded. A series of ANCOVAs, controlling for age and education were conducted to evaluate group differences in executive abilities. Executive measures included the TMT-B raw score (i.e., seconds to complete TMT-B), the raw score difference (in seconds) between TMT-A and TMT-B (TMT-BA), and the difference between a predicted TMT-B score (TMT-BP) and the obtained TMT-B score (TMT-BBP). Correlations between TMT-B, TMT-BA, and TMT-BBP and other executive functioning tests (i.e., letter fluency and animal naming) were evaluated. Results Results revealed that the HC group outperformed both retired football player groups on all measures of executive ability derived from TMT-B, p’s < 0.05, ηps2 = 0.18–0.45. Furthermore, the retired FNP TMT-B and TMT-BA were significantly correlated with both letter fluency and animal naming, r’s = −0.40 to −0.36, p’s < 0.05. Discussion We found that the HC group outperformed both retired football player groups on all three TMT variables. In our retired FNP sample, more TMT variables correlated with executive functioning measures which suggests that TMT-B and TMT-BA are likely better measures of executive ability than TMT-BBP.

2020 ◽  
Vol 35 (6) ◽  
pp. 960-960
Author(s):  
Lopez A ◽  
Lopez Palacios D ◽  
Quintana A ◽  
Gibson D ◽  
Arguelles-Borge S

Abstract Objective This study examined the role of apathy on performance of an executive functioning task. Method The data for this study was derived from the National Alzheimer’s Coordinating Center’s Uniform Data Set containing neuropsychological information for stroke patients (n = 317) who completed the Neuropsychiatric Inventory-Questionnaire (NPI-Q) and the Trail Making Test (Part B). The sample was divided into two groups. One which endorsed feelings of apathy in the last month (n = 102; mean age = 84,SD = 8.33) and a second group which denied feelings of apathy within the last month (n = 215; mean age = 86, SD = 8.02). Results After controlling for depression [as measured by the Geriatric Depression Scale (GDS)], age, gender, and motor impairment, the results of an ANCOVA showed that those who reported apathy performed significantly slower on the Trail Making Test—Part B than those who did not report it [F(1,312 = 6.01, p = .02]. Conclusions It has previously been found that cognitive performance can be impacted by depression on stroke patients. However, recently, it has been identified that apathy specifically, can have an effect on cognitive domains such as verbal learning, short-term, and long-term memory. The present study further supports that apathy may play a role in overall cognitive performance. Therefore, even if patients do not meet criteria for depression, the presence of apathy should still be taken into account. Future research should examine other possible contributing factors such as processing speed should be taken into account as they could be affecting the scores. Finally, researchers should utilize additional measures of executive functioning as only one was available for this study.


2020 ◽  
Vol 35 (6) ◽  
pp. 782-782
Author(s):  
T Scott ◽  
J Spellman ◽  
N Walker ◽  
J Rivera ◽  
D Waltzman ◽  
...  

Abstract Objective Among individuals with mild traumatic brain injury (mTBI), those with depression report greater subjective cognitive complaints than those without depression. In mTBI patients with general cognitive complaints, depression may account for poor performance on objective neuropsychological measures. This study seeks to expand this research by examining depression, subjective executive functioning (EF) complaints, and objective EF performance in Veterans with mTBI. Method Fifty-seven Veterans with deployment-related mTBI (12% female; age M = 42.0, SD = 13.6; years education M = 15.0, SD = 1.8) with (n = 29) or without (n = 28) a chart diagnosis of depression. Participants were administered the Behavioral Rating Inventory of Executive Functioning (BRIEF) and objective neuropsychological measures of working memory (i.e., Weschler Adult Intelligence Scale-IV Working Memory Index) and aspects of EF (i.e., Trail Making Test B and Delis-Kaplan Executive Functioning System (D-KEFS) subtests). Results Principal component analysis identified similar domains of EF to the BRIEF, including: task monitoring (Trail Making Test B, D-KEFS Letter Fluency, and D-KEFS Tower Test, eigenvalue = 1.93) and shifting (D-KEFS: Color-Word Interference Conditions 3 and 4, and Category Switching, eigenvalue = 1.24). Individuals with depression had greater subjective EF complaints in each BRIEF domain than non-depressed individuals (p’s ≤ .01). However, subjective complaints in these domains were not related to objective performance (r’s = −0.17,-0.19, p’s > .05). Moreover, depressed and non-depressed individuals performed similarly on all EF measures (p’s > .05). Conclusions mTBI Veterans with depression report more subjective EF complaints than those without depression. The lack of association between subjective complaints and objective EF performance suggests it is important to treat depression in mTBI patients to remedy perceived cognitive deficits.


2013 ◽  
Vol 25 (6) ◽  
pp. 334-341 ◽  
Author(s):  
Tina Gooren ◽  
Peter Schlattmann ◽  
Peter Neu

ObjectiveEven though cognitive deficits are well recognised in schizophrenia and depression, direct comparisons between the disorders are scarce in literature. This study aims to assess specificity and degree of cognitive deficits in inpatients with acute schizophrenia and unipolar major depression.MethodsA neuropsychological test battery was administered to 76 schizophrenic patients, 102 patients with unipolar major depression and 85 healthy controls (HCs), assessing verbal learning [Rey Auditory Verbal Learning Test (RAVLT)], processing speed (Trail Making Test), verbal fluency and visual memory (Wechsler Memory Scale-Revised test).ResultsBoth patient groups were significantly impaired compared with HCs with regard to all test outcomes. The schizophrenia group (SG) performed significantly worse in the Wechsler Memory Scale and verbal fluency than the depression group (DG). The DG reached significantly lower scores than the SG in the RAVLT delayed recall subtest. No significant group difference between SG and DG was found for the Trail Making Test and the RAVLT direct recall trails.ConclusionOur results indicate that cognitive impairment is present in both disorders. Schizophrenic patients performed worse than patients with unipolar depression in only two of the administered tests. Differences in cognitive performance between the groups are not as general as often assumed. Therefore, during the acute phase of illness, a diagnostic classification on the grounds of the patients’ neurocognitive performance has to be done with caution.


2021 ◽  
Vol 36 (6) ◽  
pp. 1051-1051
Author(s):  
Kendra L Pizzonia ◽  
Andrew M Bryant ◽  
Leatha A Clark ◽  
Brian C Clark ◽  
Julie A Suhr

Abstract Objective ApoE is a well-known gene carrying risk for Alzheimer’s disease and is associated with memory performance while the COMT gene is associated with executive functioning but is understudied. The present study investigated these gene interactions across cognitive domains. Method A larger study on gait and aging recruited 89 healthy community-dwelling adults over the age of 60. The primary analyses included 82 participants (67% female, mean age = 74.61, SD = 6.71). The analyses on executive functioning included 72 participants (65% female, mean age = 73.02, SD = 4.99) who completed all measures of interest. ApoE status was defined as presence/absence of Ɛ4. The rs4680 gene on the COMT allele was classified into Val/Met, Val/Val, and Met/Met genotypes. Biological sex was included as a binary term (i.e., male/female). Index variables and age corrected standard scores on the Repeatable Battery for the Assessment of Neuropsychological Status, verbal fluency, and Trail Making Test were included. Results Gene–gene interactions were found for overall cognitive functioning, immediate memory, and semantic fluency. There were main effects of sex for overall cognitive functioning, immediate memory, delayed memory, and semantic fluency. There were main effects for COMT for delayed memory and a main effect for both COMT and ApoE for visuospatial functioning, coding, and verbal fluency (all p’s < 0.05). There were no ApoE x COMT x Sex interactions and Trail Making Test B was not related to either gene or sex. Conclusion(s) Our findings suggest that both COMT and ApoE (and their interaction) influence cognition. Future research should investigate gene–gene interactions in larger samples with more comprehensive cognitive batteries.


2012 ◽  
Vol 18 (6) ◽  
pp. 1086-1090 ◽  
Author(s):  
Myriam Barandiaran ◽  
Ainara Estanga ◽  
Fermín Moreno ◽  
Begoña Indakoetxea ◽  
Ainhoa Alzualde ◽  
...  

AbstractMutations in the progranulin (PGRN) gene have been identified as a cause of frontotemporal dementia (FTD). However, little is known about the neuropsychological abilities of asymptomatic carriers of these mutations. The aim of the study was to assess cognitive functioning in asymptomatic c.709-1G>A PGRN mutation carriers. We hypothesized that poorer neuropsychological performance could be present before the development of clinically significant FTD symptoms. Thirty-two asymptomatic first-degree relatives of FTD patients carrying the c.709-1G>A mutation served as study participants, including 13 PGRN mutation carriers (A-PGRN+) and 19 non-carriers (PGRN-). A neuropsychological battery was administered. We found that the A-PGRN+ participants obtained significantly poorer scores than PGRN- individuals on tests of attention (Trail-Making Test Part A), mental flexibility (Trail-Making Test Part B), and language (Boston Naming Test). Poorer performance on these tests in asymptomatic PGRN mutation carriers may reflect a prodromal phase preceding the onset of clinically significant symptoms of FTD. (JINS, 2012, 18, 1086–1090)


CNS Spectrums ◽  
2017 ◽  
Vol 23 (1) ◽  
pp. 10-23 ◽  
Author(s):  
Ahmed Elgebaly ◽  
Mohamed Elfil ◽  
Attia Attia ◽  
Mayar Magdy ◽  
Ahmed Negida

BackgroundStudies comparing subthalamus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) for the management of Parkinson’s disease in terms of neuropsychological performance are scarce and heterogeneous. Therefore, we performed a systematic review and metaanalysis to compare neuropsychological outcomes following STN DBS versus GPi DBS.MethodsA computer literature search of PubMed, the Web of Science, and Cochrane Central was conducted. Records were screened for eligible studies, and data were extracted and synthesized using Review Manager (v. 5.3 for Windows).ResultsSeven studies were included in the qualitative synthesis. Of them, four randomized controlled trials (n=345 patients) were pooled in the metaanalysis models. The standardized mean difference (SMD) of change in the Stroop color-naming test favored the GPi DBS group (SMD=–0.31,p=0.009). However, other neuropsychological outcomes did not favor either of the two groups (Stroop word-reading:SMD=–0.21,p=0.08; the Wechsler Adult Intelligence Scale (WAIS) digits forward:SMD=0.08,p=0.47; Trail Making Test Part A:SMD=–0.05,p=0.65; WAIS–R digit symbol:SMD=–0.16,p=0.29; Trail Making Test Part B:SMD=–0.14,p=0.23; Stroop color–word interference:SMD=–0.16,p=0.18; phonemic verbal fluency: bilateral DBSSMD=–0.04,p=0.73, and unilateral DBSSMD=–0.05,p=0.83; semantic verbal fluency: bilateral DBSSMD=–0.09,p=0.37, and unilateral DBSSMD=–0.29,p=0.22; Boston Naming Test:SMD=–0.11,p=0.33; Beck Depression Inventory: bilateral DBSSMD=0.15,p=0.31, and unilateral DBSSMD=0.36,p=0.11).ConclusionsThere was no statistically significant difference in most of the neuropsychological outcomes. The present evidence does not favor any of the targets in terms of neuropsychological performance.


2020 ◽  
Vol 35 (6) ◽  
pp. 819-819
Author(s):  
Grueninger K ◽  
Yousif M ◽  
Denny A ◽  
Sohoni R ◽  
Webbe F ◽  
...  

Abstract Objective Trail Making Test—Part B (TMTB) is a common neuropsychological instrument measuring aspects of executive functioning such as set shifting and cognitive flexibility. Typically, TMTB is discontinued if not completed within 300 seconds, limiting variability in interpretation for individuals who discontinue. This study aims to alleviate this limitation by examining whether a TMT-B Efficiency (TMT-Be) score can provide useful clinical information in a memory disorder clinic population. Methods TMTB was administered to 167 patients (101 females, 66 males) as part of a neuropsychological evaluation. Diagnostic groups included: Alzheimer’s Disease (AD; N = 83), Mild Cognitive Impairment (MCI; N = 58), and Normal Cognition (N = 26). Ages ranged from 65–94. Participants completed TMTB according to standardized instructions. TMT-Be scores accounted for time, number of errors, and number of incomplete moves. Results TMT-Be scores differed significantly across diagnostic groups (ANOVA, F (2, 164) = 44.81, p < .001). Post-hoc tests using the Bonferroni correction revealed TMT-Be scores in the AD group (M = 17.48, SD = 9.23) were significantly higher than scores of the MCI group (M = 7.91, SD = 5.68) and WNL group (M = 4.65, SD = 1.67). Significant correlations between TMT-Be score and other neuropsychological measures were also found and will be presented and discussed. Conclusion Results support clinical utility of TMT-Be scores for diagnostic purposes, such as differential diagnosis of normal cognition, MCI, and AD. Further research with a larger number of participants and other populations may lend further support to the clinical utility of the TMT-Be scoring method.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2642-2642
Author(s):  
Heather Rawle ◽  
Paul Holmes ◽  
Veronica J Thomas ◽  
Ronwyn Cartwright ◽  
Jo Howard

Abstract Abstract 2642 We studied 36 patients attending the sickle cell clinic in our large adult population of over 600 patients. These patients presented to the sickle psychology service because they had a past history of a stroke, or presented with concerns about memory. An MRI brain scan and neuropsychological testing (including tests for IQ, processing speed, executive function and memory) were performed on each patient. The data were organised into four groups in terms of severity of MRI abnormalities: normal MRI n=13; silent cerebral infarcts (subcortical punctate small vessel cerebrovascular disease) n= 11; severe infarcts as an adult n=8; and severe infarcts as a child n=4. The majority of patients with a history of stroke had evidence of large vessel infarcts as well as features of deep watershed ischaemia seen in large vessel (distal internal carotid artery) disease. These groups did not differ significantly in terms of gender, phenotype, age and mood. Cognitive impairments were more prevalent in the severe infarct groups but were also found in patients with silent cerebral infarcts and normal MRIs. Executive functioning and processing speed deficits were evident in all groups but were more severe in the silent cerebral infarct and severe infarct groups. Chi-squared tests for trend showed that the following test scores tended to reduce as MRI abnormalities increased: Full-Scale IQ (p=0.016), Processing Speed Index (p=0.015), Trail Making Test A (p=0.014), Trail Making Test B (p=0.018), and FAS Verbal Fluency Test (p=0.006). This suggests that executive functioning, processing speed and full-scale IQ are particularly vulnerable to the effects of MRI abnormalities in this patient population. Although the cognitive impairments were more severe in the groups with abnormal MRIs, there was significant cognitive impairment in some patients with normal MRIs, suggesting that other factors are also causative of cognitive impairments. These factors may include physiological causes such as impaired perfusion, and psychosocial factors such as disruption to education. These results agree with a recent US study (Vichinsky et al, 2010, JAMA, 303, 1823–1831) showing cognitive impairment in patients with normal MRI scans which implies that MRI is not an adequate screening tool to identify patients with cognitive impairment. This study has important clinical implications in terms of how cognitive deficits can affect the effectiveness of patient – health care professional consultations, patients' ability to manage their SCD and adhere to medication and health care advice. It is important therefore to identify patients with SCD who have such cognitive impairments so appropriate support can be offered. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document